慢性肾脏病矿物质与骨异常(CKD-MBD)是CKD患者疾病进展过程中常见的并发症之一,也是导致患者死亡的重要原因。对该病症的认识和防治直接关系到CKD患者的生活质量及预后。从1942年我国刘士豪教授首次在国际上提出肾性骨营养不良(renal osteodystrophy)的概念,到时隔六十多年之后,2005年改善全球肾脏病预后组织(KDIGO)将CKD患者表现为钙、磷、甲状旁腺激素(PTH)或维 Chronic kidney disease Mineral and bone abnormalities (CKD-MBD) is one of the common complications in the progression of disease in CKD patients, which is also an important cause of death in patients. The understanding of the disease and prevention and treatment are directly related to the quality of life and prognosis of CKD patients. From 1942, Professor Liu Shihao in our country put forward the concept of renal osteodystrophy for the first time in the world. After more than sixty years, in 2005, KDIGO showed CKD patients as calcium, Phosphorus, parathyroid hormone (PTH) or vitamin